AbCellera Biologics
ABCL
ABCL
183 hedge funds and large institutions have $980M invested in AbCellera Biologics in 2023 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 63 increasing their positions, 55 reducing their positions, and 40 closing their positions.
Holders
183
Holders Change
-20
Holders Change %
-9.85%
% of All Funds
2.93%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
22
Increased
63
Reduced
55
Closed
40
Calls
$13.3M
Puts
$2.2M
Net Calls
+$11.1M
Net Calls Change
-$189K
Top Buyers
| 1 |
1
Norges Bank
Oslo,
Norway
|
$11.9M |
| 2 |
2
Millennium Management
New York
|
$9.1M |
| 3 |
3
Renaissance Technologies
New York
|
$21.2M |
| 4 |
HF
4
HRT Financial
New York
|
$4.19M |
| 5 |
CS
5
Credit Suisse
Zurich,
Switzerland
|
$34.7M |
